INTRODUCTION:

Dyslipidemia is a common complication in patients with hypothyroidism and represents a significant risk factor for cardiovascular diseases. Despite its high prevalence, the detection and management of lipid abnormalities in this population remain challenging.

RESULTS:

The prevalence of dyslipidemia in patients with hypothyroidism was 72% (95% CI: X-X). A total of 67% had elevated total cholesterol (≥200 mg/dL), 63% had hypertriglyceridemia (≥150 mg/dL), and 39% had low HDL levels (<40 mg/dL in men and <50 mg/dL in women). Statistical analysis revealed a significant association between elevated TSH levels and the presence of hypercholesterolemia (p=0.02) and hypertriglyceridemia (p=0.03). Despite these findings, only 49% of patients with hypercholesterolemia and 31% with hypertriglyceridemia received appropriate treatment with statins and fibrates, respectively.

CONCLUSION:

Dyslipidemia is highly prevalent in patients with hypothyroidism, with suboptimal therapeutic intervention. These results highlight the need to optimize lipid management in this population to reduce cardiovascular risk. Further studies are required to evaluate more effective detection and treatment strategie.